XML 36 R18.htm IDEA: XBRL DOCUMENT v3.22.4

Stockholders’ Equity (Tables)

9 Months Ended

Dec. 31, 2022

Stockholders' Equity Note [Abstract]

Schedule of analysis of option activity

Options outstanding and exercisable under the 2000 Plan are as follows:

		As of December 31, 2022:
Range of Prices		Options Outstanding and Exercisable				Weighted Average Remaining Life in Years				Weighted Average Exercise Price				Aggregate Intrinsic Value (In thousands)
$1.16 - $7.40			5,000				2.50			$	7.40			$	—
$13.70 - $24.40			207,037				0.78				14.63				—
			212,037				0.82			$	14.46			$	—

		As of March 31, 2022:
Range of Prices		Options Outstanding and Exercisable				Weighted Average Remaining Life in Years				Weighted Average Exercise Price				Aggregate Intrinsic Value (In thousands)
$7.40			5,000				3.25			$	7.40			$	—
$14.00 - $24.40			212,337				1.50				14.65				—
			217,337				1.54			$	14.49			$	—

Schedule of stock appreciation rights outstanding

		As of December 31, 2022:
Range of Prices		SARs Outstanding				Weighted Average Remaining Life in Years				Weighted Average Exercise Price				Aggregate Intrinsic Value (In thousands)
$0.33 - $0.74			8,650,000				8.61			$	0.56			$	—
$1.16 - $1.47			2,128,277				6.55				1.39				—
$1.71 - $2.10			2,237,493				8.36				1.92				—
$2.23 - $2.56			455,583				8.81				2.28				—
			13,471,353											$	—

		As of March 31, 2022:
Range of Prices		SARs Outstanding				Weighted Average Remaining Life in Years				Weighted Average Exercise Price				Aggregate Intrinsic Value (In thousands)
$0.54 - $0.74			5,550,000				8.74			$	0.62			$	1,208
$1.16 - $1.47			2,283,610				7.90				1.37				—
$1.71 - $2.10			2,455,738				8.91				1.97				—
$2.23 - $2.56			604,250				9.60				2.32				—
			10,893,598											$	1,208

An analysis of all SARs exercisable under the 2017 Plan as of December 31, 2022 is presented below:

SARs Exercisable				Weighted Average Remaining Life in Years				Weighted Average Exercise Price				Aggregate Intrinsic Value (In thousands)
	5,448,345				7.75			$	1.13			$	—

Schedule of SARs outstanding

		Nine Months Ended December 31, 2022
SARs Outstanding - March 31, 2022			10,893,598
Issued			3,100,000
Forfeited			(522,245	)
Total SARs Outstanding - December 31, 2022			13,471,353

Schedule of weighted average assumptions used to estimate fair value of SARs

The following weighted average assumptions were used to estimate the fair value of SARs granted as follows:

		Nine Months Ended December 31, 2022
Expected dividend yield			—
Expected equity volatility			111.89	%
Expected term (years)			6.50
Risk-free interest rate			4.49	%
Exercise price		$	0.49
Market price per share		$	0.49
Weighted average fair value per SAR		$	0.43

Schedule of stock-based compensation expense

		Three Months Ended December 31,								Nine Months Ended December 31,
		2022				2021				2022				2021
Selling, general and administrative		$	708			$	1,349			$	3,906			$	3,278

X

- Definition

Tabular disclosure of SARs outstanding.

+ References

No definition available.

+ Details

Name:	cidm_ScheduleOfSARsOutstandingTableTextBlock
Namespace Prefix:	cidm_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of employee stock purchase plan activity.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (g)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock options and stock appreciation rights that were outstanding at the beginning and end of the year, exercisable at the end of the year, and the number of stock options and stock appreciation rights that were granted, exercised or converted, forfeited, and expired during the year.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

+ Details

Name:	us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration